Search Results

Ines Liebscher, Ross Cheloha and Silvio Gutkind.

EC₅₀ and Emax uncouple affinity and efficacy, making cross-agonist comparison unreliable. Dr.

Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in

Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross

Nayara Braga Emidio, Ross Cheloha, Laura M Wingler, et al. for their work on Nanobody-Mediated Dualsteric

Ross Bathgate, Francisco Olucha-Bordonau, et al.  

Ross Cheloha's research involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional

Unusual phototransduction via cross-motif signaling from Gq to adenylyl cyclase in intrinsically photosensitive

reserve, and internalization are common confounders—access to these images supports more confident cross-series

duration, enable delayed emission readings, have narrow bands and high stokes shift, which prevent cross-excitation and cross-emission phenomena.[18] Thus, they reduce background noise, improving both the signal-to-noise

Cross-Regulation of Agonist and Guanosine Nucleotide Binding Sites.

profiles, compartmentalized GPCR signaling, and location bias.[68–70] Further, our understanding of cross-talk